ISPOR - Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population

Full Text

Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population

Abstract

Authors

T.J. Bunz C. Xu M.L. Regine J.E. Couto

Back to Volume 16, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now